nodes	percent_of_prediction	percent_of_DWPC	metapath
Trovafloxacin—TOP2A—Teniposide—lymphatic system cancer	0.493	0.588	CbGbCtD
Trovafloxacin—TOP2A—Mitoxantrone—lymphatic system cancer	0.345	0.411	CbGbCtD
Trovafloxacin—TOP2A—Etoposide—Teniposide—lymphatic system cancer	0.0013	0.195	CbGdCrCtD
Trovafloxacin—TOP2A—Podofilox—Teniposide—lymphatic system cancer	0.00099	0.149	CbGdCrCtD
Trovafloxacin—TOP2A—Vindesine—Vincristine—lymphatic system cancer	0.000934	0.14	CbGdCrCtD
Trovafloxacin—TOP2A—Vinorelbine—Vincristine—lymphatic system cancer	0.000589	0.0884	CbGdCrCtD
Trovafloxacin—TOP2A—Cladribine—Fludarabine—lymphatic system cancer	0.000446	0.0669	CbGdCrCtD
Trovafloxacin—TOP2A—Clofarabine—Fludarabine—lymphatic system cancer	0.000412	0.0618	CbGdCrCtD
Trovafloxacin—TOP2A—Vinblastine—Vincristine—lymphatic system cancer	0.000405	0.0608	CbGdCrCtD
Trovafloxacin—TOP2A—Clofarabine—Cytarabine—lymphatic system cancer	0.000389	0.0584	CbGdCrCtD
Trovafloxacin—TOP2A—Gemcitabine—Cytarabine—lymphatic system cancer	0.00036	0.0541	CbGdCrCtD
Trovafloxacin—TOP2A—Cytarabine—Fludarabine—lymphatic system cancer	0.000351	0.0526	CbGdCrCtD
Trovafloxacin—Hypersensitivity—Teniposide—lymphatic system cancer	0.000319	0.00205	CcSEcCtD
Trovafloxacin—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000319	0.00205	CcSEcCtD
Trovafloxacin—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000319	0.00205	CcSEcCtD
Trovafloxacin—Flushing—Carmustine—lymphatic system cancer	0.000318	0.00205	CcSEcCtD
Trovafloxacin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000317	0.00204	CcSEcCtD
Trovafloxacin—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.000316	0.00203	CcSEcCtD
Trovafloxacin—Anaemia—Bleomycin—lymphatic system cancer	0.000316	0.00203	CcSEcCtD
Trovafloxacin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000314	0.00202	CcSEcCtD
Trovafloxacin—Asthenia—Teniposide—lymphatic system cancer	0.000311	0.002	CcSEcCtD
Trovafloxacin—Melaena—Methotrexate—lymphatic system cancer	0.000309	0.00199	CcSEcCtD
Trovafloxacin—Malaise—Bleomycin—lymphatic system cancer	0.000308	0.00198	CcSEcCtD
Trovafloxacin—Pruritus—Teniposide—lymphatic system cancer	0.000306	0.00197	CcSEcCtD
Trovafloxacin—Leukopenia—Bleomycin—lymphatic system cancer	0.000306	0.00197	CcSEcCtD
Trovafloxacin—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000302	0.00194	CcSEcCtD
Trovafloxacin—Body temperature increased—Fludarabine—lymphatic system cancer	0.000301	0.00193	CcSEcCtD
Trovafloxacin—Vaginal infection—Methotrexate—lymphatic system cancer	0.000299	0.00192	CcSEcCtD
Trovafloxacin—Cough—Bleomycin—lymphatic system cancer	0.000298	0.00192	CcSEcCtD
Trovafloxacin—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000297	0.00191	CcSEcCtD
Trovafloxacin—Diarrhoea—Teniposide—lymphatic system cancer	0.000296	0.0019	CcSEcCtD
Trovafloxacin—Chest pain—Bleomycin—lymphatic system cancer	0.000291	0.00187	CcSEcCtD
Trovafloxacin—Myalgia—Bleomycin—lymphatic system cancer	0.000291	0.00187	CcSEcCtD
Trovafloxacin—Back pain—Carmustine—lymphatic system cancer	0.000289	0.00186	CcSEcCtD
Trovafloxacin—Discomfort—Bleomycin—lymphatic system cancer	0.000288	0.00185	CcSEcCtD
Trovafloxacin—Chills—Mitoxantrone—lymphatic system cancer	0.000286	0.00184	CcSEcCtD
Trovafloxacin—Confusional state—Bleomycin—lymphatic system cancer	0.000281	0.00181	CcSEcCtD
Trovafloxacin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00028	0.0018	CcSEcCtD
Trovafloxacin—Tremor—Carmustine—lymphatic system cancer	0.00028	0.0018	CcSEcCtD
Trovafloxacin—Oedema—Bleomycin—lymphatic system cancer	0.000279	0.00179	CcSEcCtD
Trovafloxacin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000279	0.00179	CcSEcCtD
Trovafloxacin—Anaemia—Carmustine—lymphatic system cancer	0.000276	0.00177	CcSEcCtD
Trovafloxacin—Back pain—Vincristine—lymphatic system cancer	0.000276	0.00177	CcSEcCtD
Trovafloxacin—Vomiting—Teniposide—lymphatic system cancer	0.000275	0.00177	CcSEcCtD
Trovafloxacin—Sepsis—Methotrexate—lymphatic system cancer	0.000275	0.00176	CcSEcCtD
Trovafloxacin—Agitation—Carmustine—lymphatic system cancer	0.000274	0.00176	CcSEcCtD
Trovafloxacin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000273	0.00176	CcSEcCtD
Trovafloxacin—Asthenia—Fludarabine—lymphatic system cancer	0.000273	0.00176	CcSEcCtD
Trovafloxacin—Rash—Teniposide—lymphatic system cancer	0.000273	0.00176	CcSEcCtD
Trovafloxacin—Dermatitis—Teniposide—lymphatic system cancer	0.000273	0.00175	CcSEcCtD
Trovafloxacin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000272	0.00175	CcSEcCtD
Trovafloxacin—Headache—Teniposide—lymphatic system cancer	0.000271	0.00174	CcSEcCtD
Trovafloxacin—Pruritus—Fludarabine—lymphatic system cancer	0.000269	0.00173	CcSEcCtD
Trovafloxacin—Back pain—Mitoxantrone—lymphatic system cancer	0.000268	0.00173	CcSEcCtD
Trovafloxacin—Leukopenia—Carmustine—lymphatic system cancer	0.000267	0.00172	CcSEcCtD
Trovafloxacin—Anorexia—Bleomycin—lymphatic system cancer	0.000266	0.00171	CcSEcCtD
Trovafloxacin—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000265	0.0017	CcSEcCtD
Trovafloxacin—Anaemia—Vincristine—lymphatic system cancer	0.000263	0.00169	CcSEcCtD
Trovafloxacin—Agitation—Vincristine—lymphatic system cancer	0.000262	0.00168	CcSEcCtD
Trovafloxacin—Photosensitivity—Methotrexate—lymphatic system cancer	0.000262	0.00168	CcSEcCtD
Trovafloxacin—Hypotension—Bleomycin—lymphatic system cancer	0.000261	0.00168	CcSEcCtD
Trovafloxacin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00026	0.00167	CcSEcCtD
Trovafloxacin—Convulsion—Carmustine—lymphatic system cancer	0.000259	0.00166	CcSEcCtD
Trovafloxacin—Hypertension—Carmustine—lymphatic system cancer	0.000258	0.00166	CcSEcCtD
Trovafloxacin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000258	0.00165	CcSEcCtD
Trovafloxacin—Nausea—Teniposide—lymphatic system cancer	0.000257	0.00165	CcSEcCtD
Trovafloxacin—Anaemia—Mitoxantrone—lymphatic system cancer	0.000257	0.00165	CcSEcCtD
Trovafloxacin—Vertigo—Vincristine—lymphatic system cancer	0.000256	0.00165	CcSEcCtD
Trovafloxacin—Hepatic failure—Methotrexate—lymphatic system cancer	0.000256	0.00164	CcSEcCtD
Trovafloxacin—Leukopenia—Vincristine—lymphatic system cancer	0.000255	0.00164	CcSEcCtD
Trovafloxacin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000254	0.00163	CcSEcCtD
Trovafloxacin—Chest pain—Carmustine—lymphatic system cancer	0.000254	0.00163	CcSEcCtD
Trovafloxacin—Myalgia—Carmustine—lymphatic system cancer	0.000254	0.00163	CcSEcCtD
Trovafloxacin—Anxiety—Carmustine—lymphatic system cancer	0.000253	0.00163	CcSEcCtD
Trovafloxacin—TOP2A—Azacitidine—Fludarabine—lymphatic system cancer	0.000251	0.0377	CbGdCrCtD
Trovafloxacin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000251	0.00161	CcSEcCtD
Trovafloxacin—Malaise—Mitoxantrone—lymphatic system cancer	0.00025	0.00161	CcSEcCtD
Trovafloxacin—Dyspnoea—Bleomycin—lymphatic system cancer	0.000249	0.0016	CcSEcCtD
Trovafloxacin—Renal failure acute—Methotrexate—lymphatic system cancer	0.000249	0.0016	CcSEcCtD
Trovafloxacin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000248	0.0016	CcSEcCtD
Trovafloxacin—Convulsion—Vincristine—lymphatic system cancer	0.000247	0.00159	CcSEcCtD
Trovafloxacin—Hypertension—Vincristine—lymphatic system cancer	0.000246	0.00158	CcSEcCtD
Trovafloxacin—Confusional state—Carmustine—lymphatic system cancer	0.000246	0.00158	CcSEcCtD
Trovafloxacin—Oedema—Carmustine—lymphatic system cancer	0.000244	0.00157	CcSEcCtD
Trovafloxacin—Decreased appetite—Bleomycin—lymphatic system cancer	0.000243	0.00156	CcSEcCtD
Trovafloxacin—Myalgia—Vincristine—lymphatic system cancer	0.000243	0.00156	CcSEcCtD
Trovafloxacin—Cough—Mitoxantrone—lymphatic system cancer	0.000242	0.00156	CcSEcCtD
Trovafloxacin—Vomiting—Fludarabine—lymphatic system cancer	0.000242	0.00156	CcSEcCtD
Trovafloxacin—Convulsion—Mitoxantrone—lymphatic system cancer	0.00024	0.00155	CcSEcCtD
Trovafloxacin—Rash—Fludarabine—lymphatic system cancer	0.00024	0.00154	CcSEcCtD
Trovafloxacin—Dermatitis—Fludarabine—lymphatic system cancer	0.00024	0.00154	CcSEcCtD
Trovafloxacin—Hypertension—Mitoxantrone—lymphatic system cancer	0.00024	0.00154	CcSEcCtD
Trovafloxacin—Pain—Bleomycin—lymphatic system cancer	0.000239	0.00153	CcSEcCtD
Trovafloxacin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000239	0.00153	CcSEcCtD
Trovafloxacin—Headache—Fludarabine—lymphatic system cancer	0.000239	0.00153	CcSEcCtD
Trovafloxacin—Tachycardia—Carmustine—lymphatic system cancer	0.000238	0.00153	CcSEcCtD
Trovafloxacin—TOP2A—Azacitidine—Cytarabine—lymphatic system cancer	0.000237	0.0356	CbGdCrCtD
Trovafloxacin—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000237	0.00152	CcSEcCtD
Trovafloxacin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000236	0.00152	CcSEcCtD
Trovafloxacin—Chest pain—Mitoxantrone—lymphatic system cancer	0.000236	0.00152	CcSEcCtD
Trovafloxacin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000236	0.00152	CcSEcCtD
Trovafloxacin—Anxiety—Mitoxantrone—lymphatic system cancer	0.000235	0.00151	CcSEcCtD
Trovafloxacin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000233	0.0015	CcSEcCtD
Trovafloxacin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000233	0.00149	CcSEcCtD
Trovafloxacin—Oedema—Vincristine—lymphatic system cancer	0.000233	0.00149	CcSEcCtD
Trovafloxacin—Anorexia—Carmustine—lymphatic system cancer	0.000232	0.00149	CcSEcCtD
Trovafloxacin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00023	0.00148	CcSEcCtD
Trovafloxacin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00023	0.00148	CcSEcCtD
Trovafloxacin—Confusional state—Mitoxantrone—lymphatic system cancer	0.000228	0.00147	CcSEcCtD
Trovafloxacin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000228	0.00146	CcSEcCtD
Trovafloxacin—Hypotension—Carmustine—lymphatic system cancer	0.000228	0.00146	CcSEcCtD
Trovafloxacin—Oedema—Mitoxantrone—lymphatic system cancer	0.000227	0.00146	CcSEcCtD
Trovafloxacin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000227	0.00146	CcSEcCtD
Trovafloxacin—Nausea—Fludarabine—lymphatic system cancer	0.000226	0.00145	CcSEcCtD
Trovafloxacin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000225	0.00144	CcSEcCtD
Trovafloxacin—Shock—Mitoxantrone—lymphatic system cancer	0.000223	0.00143	CcSEcCtD
Trovafloxacin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000222	0.00143	CcSEcCtD
Trovafloxacin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000222	0.00143	CcSEcCtD
Trovafloxacin—Urticaria—Bleomycin—lymphatic system cancer	0.000222	0.00143	CcSEcCtD
Trovafloxacin—Anorexia—Vincristine—lymphatic system cancer	0.000222	0.00142	CcSEcCtD
Trovafloxacin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000221	0.00142	CcSEcCtD
Trovafloxacin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000221	0.00142	CcSEcCtD
Trovafloxacin—Insomnia—Carmustine—lymphatic system cancer	0.00022	0.00142	CcSEcCtD
Trovafloxacin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00022	0.00141	CcSEcCtD
Trovafloxacin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000219	0.00141	CcSEcCtD
Trovafloxacin—Paraesthesia—Carmustine—lymphatic system cancer	0.000219	0.00141	CcSEcCtD
Trovafloxacin—Mood swings—Methotrexate—lymphatic system cancer	0.000218	0.0014	CcSEcCtD
Trovafloxacin—Hypotension—Vincristine—lymphatic system cancer	0.000217	0.0014	CcSEcCtD
Trovafloxacin—Dyspnoea—Carmustine—lymphatic system cancer	0.000217	0.0014	CcSEcCtD
Trovafloxacin—Somnolence—Carmustine—lymphatic system cancer	0.000217	0.00139	CcSEcCtD
Trovafloxacin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000216	0.00139	CcSEcCtD
Trovafloxacin—Ataxia—Methotrexate—lymphatic system cancer	0.000216	0.00139	CcSEcCtD
Trovafloxacin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000212	0.00136	CcSEcCtD
Trovafloxacin—Decreased appetite—Carmustine—lymphatic system cancer	0.000212	0.00136	CcSEcCtD
Trovafloxacin—Hypotension—Mitoxantrone—lymphatic system cancer	0.000212	0.00136	CcSEcCtD
Trovafloxacin—Insomnia—Vincristine—lymphatic system cancer	0.00021	0.00135	CcSEcCtD
Trovafloxacin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00021	0.00135	CcSEcCtD
Trovafloxacin—Paraesthesia—Vincristine—lymphatic system cancer	0.000209	0.00134	CcSEcCtD
Trovafloxacin—Constipation—Carmustine—lymphatic system cancer	0.000208	0.00134	CcSEcCtD
Trovafloxacin—Pain—Carmustine—lymphatic system cancer	0.000208	0.00134	CcSEcCtD
Trovafloxacin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000206	0.00133	CcSEcCtD
Trovafloxacin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000206	0.00132	CcSEcCtD
Trovafloxacin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000203	0.00131	CcSEcCtD
Trovafloxacin—Decreased appetite—Vincristine—lymphatic system cancer	0.000202	0.0013	CcSEcCtD
Trovafloxacin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000202	0.0013	CcSEcCtD
Trovafloxacin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000201	0.00129	CcSEcCtD
Trovafloxacin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000201	0.00129	CcSEcCtD
Trovafloxacin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000201	0.00129	CcSEcCtD
Trovafloxacin—Fatigue—Vincristine—lymphatic system cancer	0.000201	0.00129	CcSEcCtD
Trovafloxacin—Asthenia—Bleomycin—lymphatic system cancer	0.0002	0.00129	CcSEcCtD
Trovafloxacin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000199	0.00128	CcSEcCtD
Trovafloxacin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000199	0.00128	CcSEcCtD
Trovafloxacin—Pain—Vincristine—lymphatic system cancer	0.000199	0.00128	CcSEcCtD
Trovafloxacin—Constipation—Vincristine—lymphatic system cancer	0.000199	0.00128	CcSEcCtD
Trovafloxacin—Asthma—Methotrexate—lymphatic system cancer	0.000198	0.00128	CcSEcCtD
Trovafloxacin—Pruritus—Bleomycin—lymphatic system cancer	0.000197	0.00127	CcSEcCtD
Trovafloxacin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000197	0.00127	CcSEcCtD
Trovafloxacin—Eosinophilia—Methotrexate—lymphatic system cancer	0.000197	0.00126	CcSEcCtD
Trovafloxacin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000195	0.00126	CcSEcCtD
Trovafloxacin—Pancreatitis—Methotrexate—lymphatic system cancer	0.000195	0.00125	CcSEcCtD
Trovafloxacin—Pain—Mitoxantrone—lymphatic system cancer	0.000194	0.00124	CcSEcCtD
Trovafloxacin—Constipation—Mitoxantrone—lymphatic system cancer	0.000194	0.00124	CcSEcCtD
Trovafloxacin—Abdominal pain—Carmustine—lymphatic system cancer	0.000193	0.00124	CcSEcCtD
Trovafloxacin—Body temperature increased—Carmustine—lymphatic system cancer	0.000193	0.00124	CcSEcCtD
Trovafloxacin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00019	0.00122	CcSEcCtD
Trovafloxacin—Pancytopenia—Methotrexate—lymphatic system cancer	0.000188	0.00121	CcSEcCtD
Trovafloxacin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000187	0.0012	CcSEcCtD
Trovafloxacin—Dysuria—Methotrexate—lymphatic system cancer	0.000186	0.00119	CcSEcCtD
Trovafloxacin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000185	0.00119	CcSEcCtD
Trovafloxacin—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000184	0.00119	CcSEcCtD
Trovafloxacin—Body temperature increased—Vincristine—lymphatic system cancer	0.000184	0.00118	CcSEcCtD
Trovafloxacin—Abdominal pain—Vincristine—lymphatic system cancer	0.000184	0.00118	CcSEcCtD
Trovafloxacin—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000183	0.00117	CcSEcCtD
Trovafloxacin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000181	0.00116	CcSEcCtD
Trovafloxacin—Urticaria—Mitoxantrone—lymphatic system cancer	0.00018	0.00116	CcSEcCtD
Trovafloxacin—Hypersensitivity—Carmustine—lymphatic system cancer	0.00018	0.00115	CcSEcCtD
Trovafloxacin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000179	0.00115	CcSEcCtD
Trovafloxacin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000179	0.00115	CcSEcCtD
Trovafloxacin—Vomiting—Bleomycin—lymphatic system cancer	0.000177	0.00114	CcSEcCtD
Trovafloxacin—Rash—Bleomycin—lymphatic system cancer	0.000176	0.00113	CcSEcCtD
Trovafloxacin—Dermatitis—Bleomycin—lymphatic system cancer	0.000176	0.00113	CcSEcCtD
Trovafloxacin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000175	0.00113	CcSEcCtD
Trovafloxacin—Asthenia—Carmustine—lymphatic system cancer	0.000175	0.00112	CcSEcCtD
Trovafloxacin—Stomatitis—Methotrexate—lymphatic system cancer	0.000172	0.00111	CcSEcCtD
Trovafloxacin—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000172	0.00111	CcSEcCtD
Trovafloxacin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000171	0.0011	CcSEcCtD
Trovafloxacin—Epistaxis—Methotrexate—lymphatic system cancer	0.000167	0.00107	CcSEcCtD
Trovafloxacin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000167	0.00107	CcSEcCtD
Trovafloxacin—Asthenia—Vincristine—lymphatic system cancer	0.000167	0.00107	CcSEcCtD
Trovafloxacin—Diarrhoea—Carmustine—lymphatic system cancer	0.000167	0.00107	CcSEcCtD
Trovafloxacin—Nausea—Bleomycin—lymphatic system cancer	0.000166	0.00107	CcSEcCtD
Trovafloxacin—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000165	0.00106	CcSEcCtD
Trovafloxacin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000163	0.00104	CcSEcCtD
Trovafloxacin—Dizziness—Carmustine—lymphatic system cancer	0.000161	0.00104	CcSEcCtD
Trovafloxacin—Haemoglobin—Methotrexate—lymphatic system cancer	0.00016	0.00103	CcSEcCtD
Trovafloxacin—Diarrhoea—Vincristine—lymphatic system cancer	0.000159	0.00102	CcSEcCtD
Trovafloxacin—Haemorrhage—Methotrexate—lymphatic system cancer	0.000159	0.00102	CcSEcCtD
Trovafloxacin—Hepatitis—Methotrexate—lymphatic system cancer	0.000159	0.00102	CcSEcCtD
Trovafloxacin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000155	0.000996	CcSEcCtD
Trovafloxacin—Vomiting—Carmustine—lymphatic system cancer	0.000155	0.000996	CcSEcCtD
Trovafloxacin—Dizziness—Vincristine—lymphatic system cancer	0.000154	0.000988	CcSEcCtD
Trovafloxacin—Rash—Carmustine—lymphatic system cancer	0.000154	0.000987	CcSEcCtD
Trovafloxacin—Dermatitis—Carmustine—lymphatic system cancer	0.000153	0.000986	CcSEcCtD
Trovafloxacin—Visual impairment—Methotrexate—lymphatic system cancer	0.000153	0.000984	CcSEcCtD
Trovafloxacin—Headache—Carmustine—lymphatic system cancer	0.000153	0.000981	CcSEcCtD
Trovafloxacin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00015	0.000965	CcSEcCtD
Trovafloxacin—Tinnitus—Methotrexate—lymphatic system cancer	0.000148	0.000952	CcSEcCtD
Trovafloxacin—Vomiting—Vincristine—lymphatic system cancer	0.000148	0.00095	CcSEcCtD
Trovafloxacin—Rash—Vincristine—lymphatic system cancer	0.000147	0.000942	CcSEcCtD
Trovafloxacin—Dermatitis—Vincristine—lymphatic system cancer	0.000147	0.000942	CcSEcCtD
Trovafloxacin—Headache—Vincristine—lymphatic system cancer	0.000146	0.000936	CcSEcCtD
Trovafloxacin—Nausea—Carmustine—lymphatic system cancer	0.000145	0.00093	CcSEcCtD
Trovafloxacin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000144	0.000926	CcSEcCtD
Trovafloxacin—Rash—Mitoxantrone—lymphatic system cancer	0.000143	0.000918	CcSEcCtD
Trovafloxacin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000143	0.000917	CcSEcCtD
Trovafloxacin—Chills—Methotrexate—lymphatic system cancer	0.000143	0.000916	CcSEcCtD
Trovafloxacin—Headache—Mitoxantrone—lymphatic system cancer	0.000142	0.000912	CcSEcCtD
Trovafloxacin—Nausea—Vincristine—lymphatic system cancer	0.000138	0.000888	CcSEcCtD
Trovafloxacin—Dysgeusia—Methotrexate—lymphatic system cancer	0.000135	0.00087	CcSEcCtD
Trovafloxacin—Nausea—Mitoxantrone—lymphatic system cancer	0.000135	0.000865	CcSEcCtD
Trovafloxacin—Back pain—Methotrexate—lymphatic system cancer	0.000134	0.00086	CcSEcCtD
Trovafloxacin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000128	0.000825	CcSEcCtD
Trovafloxacin—Anaemia—Methotrexate—lymphatic system cancer	0.000128	0.000821	CcSEcCtD
Trovafloxacin—Malaise—Methotrexate—lymphatic system cancer	0.000125	0.000801	CcSEcCtD
Trovafloxacin—Vertigo—Methotrexate—lymphatic system cancer	0.000124	0.000798	CcSEcCtD
Trovafloxacin—Leukopenia—Methotrexate—lymphatic system cancer	0.000124	0.000795	CcSEcCtD
Trovafloxacin—Cough—Methotrexate—lymphatic system cancer	0.000121	0.000775	CcSEcCtD
Trovafloxacin—Convulsion—Methotrexate—lymphatic system cancer	0.00012	0.00077	CcSEcCtD
Trovafloxacin—Chest pain—Methotrexate—lymphatic system cancer	0.000118	0.000757	CcSEcCtD
Trovafloxacin—Myalgia—Methotrexate—lymphatic system cancer	0.000118	0.000757	CcSEcCtD
Trovafloxacin—Arthralgia—Methotrexate—lymphatic system cancer	0.000118	0.000757	CcSEcCtD
Trovafloxacin—Discomfort—Methotrexate—lymphatic system cancer	0.000116	0.000747	CcSEcCtD
Trovafloxacin—Confusional state—Methotrexate—lymphatic system cancer	0.000114	0.000731	CcSEcCtD
Trovafloxacin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000113	0.000725	CcSEcCtD
Trovafloxacin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000111	0.00071	CcSEcCtD
Trovafloxacin—Skin disorder—Methotrexate—lymphatic system cancer	0.00011	0.000704	CcSEcCtD
Trovafloxacin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000109	0.000701	CcSEcCtD
Trovafloxacin—Anorexia—Methotrexate—lymphatic system cancer	0.000108	0.000691	CcSEcCtD
Trovafloxacin—Hypotension—Methotrexate—lymphatic system cancer	0.000105	0.000678	CcSEcCtD
Trovafloxacin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000103	0.000661	CcSEcCtD
Trovafloxacin—Insomnia—Methotrexate—lymphatic system cancer	0.000102	0.000656	CcSEcCtD
Trovafloxacin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000101	0.000651	CcSEcCtD
Trovafloxacin—Dyspnoea—Methotrexate—lymphatic system cancer	0.000101	0.000647	CcSEcCtD
Trovafloxacin—Somnolence—Methotrexate—lymphatic system cancer	0.0001	0.000645	CcSEcCtD
Trovafloxacin—Dyspepsia—Methotrexate—lymphatic system cancer	9.93e-05	0.000638	CcSEcCtD
Trovafloxacin—Decreased appetite—Methotrexate—lymphatic system cancer	9.81e-05	0.00063	CcSEcCtD
Trovafloxacin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	9.74e-05	0.000626	CcSEcCtD
Trovafloxacin—Fatigue—Methotrexate—lymphatic system cancer	9.73e-05	0.000625	CcSEcCtD
Trovafloxacin—Pain—Methotrexate—lymphatic system cancer	9.65e-05	0.00062	CcSEcCtD
Trovafloxacin—Feeling abnormal—Methotrexate—lymphatic system cancer	9.3e-05	0.000598	CcSEcCtD
Trovafloxacin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	9.23e-05	0.000593	CcSEcCtD
Trovafloxacin—Urticaria—Methotrexate—lymphatic system cancer	8.97e-05	0.000576	CcSEcCtD
Trovafloxacin—Abdominal pain—Methotrexate—lymphatic system cancer	8.92e-05	0.000573	CcSEcCtD
Trovafloxacin—Body temperature increased—Methotrexate—lymphatic system cancer	8.92e-05	0.000573	CcSEcCtD
Trovafloxacin—Hypersensitivity—Methotrexate—lymphatic system cancer	8.32e-05	0.000534	CcSEcCtD
Trovafloxacin—Asthenia—Methotrexate—lymphatic system cancer	8.1e-05	0.00052	CcSEcCtD
Trovafloxacin—Pruritus—Methotrexate—lymphatic system cancer	7.98e-05	0.000513	CcSEcCtD
Trovafloxacin—Diarrhoea—Methotrexate—lymphatic system cancer	7.72e-05	0.000496	CcSEcCtD
Trovafloxacin—Dizziness—Methotrexate—lymphatic system cancer	7.46e-05	0.00048	CcSEcCtD
Trovafloxacin—Vomiting—Methotrexate—lymphatic system cancer	7.18e-05	0.000461	CcSEcCtD
Trovafloxacin—Rash—Methotrexate—lymphatic system cancer	7.12e-05	0.000457	CcSEcCtD
Trovafloxacin—Dermatitis—Methotrexate—lymphatic system cancer	7.11e-05	0.000457	CcSEcCtD
Trovafloxacin—Headache—Methotrexate—lymphatic system cancer	7.07e-05	0.000454	CcSEcCtD
Trovafloxacin—Nausea—Methotrexate—lymphatic system cancer	6.7e-05	0.000431	CcSEcCtD
